nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CYP3A4—Everolimus—kidney cancer	0.0802	0.141	CbGbCtD
Prasugrel—ALB—Erlotinib—kidney cancer	0.0648	0.114	CbGbCtD
Prasugrel—CYP3A4—Temsirolimus—kidney cancer	0.0541	0.0949	CbGbCtD
Prasugrel—CYP2B6—Sorafenib—kidney cancer	0.0537	0.0942	CbGbCtD
Prasugrel—CYP2C9—Capecitabine—kidney cancer	0.051	0.0894	CbGbCtD
Prasugrel—CYP2C19—Sorafenib—kidney cancer	0.0341	0.0598	CbGbCtD
Prasugrel—CYP2B6—Doxorubicin—kidney cancer	0.0326	0.0571	CbGbCtD
Prasugrel—CYP2C9—Paclitaxel—kidney cancer	0.0319	0.056	CbGbCtD
Prasugrel—CYP3A4—Pazopanib—kidney cancer	0.0284	0.0499	CbGbCtD
Prasugrel—CYP2C9—Sorafenib—kidney cancer	0.0284	0.0498	CbGbCtD
Prasugrel—CYP3A4—Erlotinib—kidney cancer	0.0203	0.0356	CbGbCtD
Prasugrel—CYP3A4—Paclitaxel—kidney cancer	0.0186	0.0326	CbGbCtD
Prasugrel—CYP3A4—Sorafenib—kidney cancer	0.0165	0.0289	CbGbCtD
Prasugrel—CYP3A4—Vinblastine—kidney cancer	0.0163	0.0286	CbGbCtD
Prasugrel—CYP3A4—Vincristine—kidney cancer	0.016	0.0281	CbGbCtD
Prasugrel—CYP3A4—Sunitinib—kidney cancer	0.0134	0.0234	CbGbCtD
Prasugrel—CYP3A4—Doxorubicin—kidney cancer	0.01	0.0176	CbGbCtD
Prasugrel—CYP2C19—urine—kidney cancer	0.00518	0.154	CbGeAlD
Prasugrel—CYP2C9—urine—kidney cancer	0.00402	0.119	CbGeAlD
Prasugrel—CYP3A4—urine—kidney cancer	0.00306	0.0911	CbGeAlD
Prasugrel—CES2—nephron tubule—kidney cancer	0.00303	0.09	CbGeAlD
Prasugrel—CES2—renal system—kidney cancer	0.00275	0.0818	CbGeAlD
Prasugrel—CES2—kidney—kidney cancer	0.00266	0.0791	CbGeAlD
Prasugrel—CES2—cortex of kidney—kidney cancer	0.00259	0.077	CbGeAlD
Prasugrel—CES2—gonad—kidney cancer	0.00247	0.0734	CbGeAlD
Prasugrel—CES2—cardiac atrium—kidney cancer	0.00246	0.0733	CbGeAlD
Prasugrel—Clopidogrel—ABCB1—kidney cancer	0.00123	1	CrCbGaD
Prasugrel—CYP2B6—nephron tubule—kidney cancer	0.00109	0.0325	CbGeAlD
Prasugrel—CYP2B6—renal system—kidney cancer	0.000993	0.0295	CbGeAlD
Prasugrel—CYP2B6—kidney—kidney cancer	0.00096	0.0285	CbGeAlD
Prasugrel—CYP2B6—gonad—kidney cancer	0.000891	0.0265	CbGeAlD
Prasugrel—CYP3A4—renal system—kidney cancer	0.00075	0.0223	CbGeAlD
Prasugrel—CYP3A4—kidney—kidney cancer	0.000725	0.0215	CbGeAlD
Prasugrel—Anaemia—Sunitinib—kidney cancer	0.000538	0.00166	CcSEcCtD
Prasugrel—Thrombocytopenia—Erlotinib—kidney cancer	0.000538	0.00165	CcSEcCtD
Prasugrel—Haemorrhage—Gemcitabine—kidney cancer	0.000537	0.00165	CcSEcCtD
Prasugrel—Skin disorder—Erlotinib—kidney cancer	0.000533	0.00164	CcSEcCtD
Prasugrel—Pain in extremity—Capecitabine—kidney cancer	0.000533	0.00164	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000533	0.00164	CcSEcCtD
Prasugrel—Angioedema—Sunitinib—kidney cancer	0.000532	0.00164	CcSEcCtD
Prasugrel—Hypotension—Everolimus—kidney cancer	0.000532	0.00164	CcSEcCtD
Prasugrel—Urinary tract disorder—Gemcitabine—kidney cancer	0.00053	0.00163	CcSEcCtD
Prasugrel—Oedema peripheral—Gemcitabine—kidney cancer	0.000529	0.00163	CcSEcCtD
Prasugrel—Cough—Sorafenib—kidney cancer	0.000528	0.00163	CcSEcCtD
Prasugrel—Urethral disorder—Gemcitabine—kidney cancer	0.000526	0.00162	CcSEcCtD
Prasugrel—Rectal haemorrhage—Doxorubicin—kidney cancer	0.000524	0.00161	CcSEcCtD
Prasugrel—Diarrhoea—Temsirolimus—kidney cancer	0.000523	0.00161	CcSEcCtD
Prasugrel—Hypertension—Sorafenib—kidney cancer	0.000522	0.00161	CcSEcCtD
Prasugrel—Leukopenia—Sunitinib—kidney cancer	0.000521	0.0016	CcSEcCtD
Prasugrel—Asthenia—Pazopanib—kidney cancer	0.000517	0.00159	CcSEcCtD
Prasugrel—Angiopathy—Vincristine—kidney cancer	0.000513	0.00158	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000512	0.00158	CcSEcCtD
Prasugrel—Mediastinal disorder—Vincristine—kidney cancer	0.00051	0.00157	CcSEcCtD
Prasugrel—Anaemia—Dactinomycin—kidney cancer	0.00051	0.00157	CcSEcCtD
Prasugrel—Cough—Sunitinib—kidney cancer	0.000508	0.00156	CcSEcCtD
Prasugrel—Dyspnoea—Everolimus—kidney cancer	0.000507	0.00156	CcSEcCtD
Prasugrel—Dizziness—Temsirolimus—kidney cancer	0.000506	0.00156	CcSEcCtD
Prasugrel—Hypertension—Sunitinib—kidney cancer	0.000503	0.00155	CcSEcCtD
Prasugrel—Anaphylactic shock—Sorafenib—kidney cancer	0.000494	0.00152	CcSEcCtD
Prasugrel—Leukopenia—Dactinomycin—kidney cancer	0.000493	0.00152	CcSEcCtD
Prasugrel—Diarrhoea—Pazopanib—kidney cancer	0.000493	0.00152	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000492	0.00152	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Everolimus—kidney cancer	0.000491	0.00151	CcSEcCtD
Prasugrel—Fatigue—Everolimus—kidney cancer	0.000491	0.00151	CcSEcCtD
Prasugrel—Dyspnoea—Erlotinib—kidney cancer	0.000489	0.00151	CcSEcCtD
Prasugrel—Angiopathy—Gemcitabine—kidney cancer	0.000487	0.0015	CcSEcCtD
Prasugrel—Immune system disorder—Gemcitabine—kidney cancer	0.000485	0.00149	CcSEcCtD
Prasugrel—Mediastinal disorder—Gemcitabine—kidney cancer	0.000484	0.00149	CcSEcCtD
Prasugrel—Thrombocytopenia—Sorafenib—kidney cancer	0.000484	0.00149	CcSEcCtD
Prasugrel—Rash—Temsirolimus—kidney cancer	0.000482	0.00148	CcSEcCtD
Prasugrel—Dermatitis—Temsirolimus—kidney cancer	0.000482	0.00148	CcSEcCtD
Prasugrel—Skin disorder—Sorafenib—kidney cancer	0.00048	0.00148	CcSEcCtD
Prasugrel—Headache—Temsirolimus—kidney cancer	0.000479	0.00148	CcSEcCtD
Prasugrel—Haematuria—Paclitaxel—kidney cancer	0.000477	0.00147	CcSEcCtD
Prasugrel—Dizziness—Pazopanib—kidney cancer	0.000477	0.00147	CcSEcCtD
Prasugrel—Back pain—Vincristine—kidney cancer	0.000476	0.00147	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000474	0.00146	CcSEcCtD
Prasugrel—Fatigue—Erlotinib—kidney cancer	0.000473	0.00146	CcSEcCtD
Prasugrel—Epistaxis—Paclitaxel—kidney cancer	0.000472	0.00145	CcSEcCtD
Prasugrel—Thrombocytopenia—Sunitinib—kidney cancer	0.000465	0.00143	CcSEcCtD
Prasugrel—Skin disorder—Sunitinib—kidney cancer	0.000462	0.00142	CcSEcCtD
Prasugrel—Bradycardia—Paclitaxel—kidney cancer	0.000457	0.00141	CcSEcCtD
Prasugrel—Anaemia—Vincristine—kidney cancer	0.000455	0.0014	CcSEcCtD
Prasugrel—Rash—Pazopanib—kidney cancer	0.000454	0.0014	CcSEcCtD
Prasugrel—Nausea—Temsirolimus—kidney cancer	0.000454	0.0014	CcSEcCtD
Prasugrel—Dermatitis—Pazopanib—kidney cancer	0.000454	0.0014	CcSEcCtD
Prasugrel—Back pain—Gemcitabine—kidney cancer	0.000452	0.00139	CcSEcCtD
Prasugrel—Haemoglobin—Paclitaxel—kidney cancer	0.000452	0.00139	CcSEcCtD
Prasugrel—Headache—Pazopanib—kidney cancer	0.000451	0.00139	CcSEcCtD
Prasugrel—Body temperature increased—Everolimus—kidney cancer	0.00045	0.00138	CcSEcCtD
Prasugrel—Haemorrhage—Paclitaxel—kidney cancer	0.000449	0.00138	CcSEcCtD
Prasugrel—Urinary tract disorder—Paclitaxel—kidney cancer	0.000444	0.00137	CcSEcCtD
Prasugrel—Oedema peripheral—Paclitaxel—kidney cancer	0.000443	0.00136	CcSEcCtD
Prasugrel—Leukopenia—Vincristine—kidney cancer	0.000441	0.00136	CcSEcCtD
Prasugrel—Urethral disorder—Paclitaxel—kidney cancer	0.000441	0.00136	CcSEcCtD
Prasugrel—Thrombocytopenia—Dactinomycin—kidney cancer	0.000441	0.00136	CcSEcCtD
Prasugrel—Dyspnoea—Sorafenib—kidney cancer	0.00044	0.00136	CcSEcCtD
Prasugrel—Body temperature increased—Erlotinib—kidney cancer	0.000434	0.00134	CcSEcCtD
Prasugrel—Anaemia—Gemcitabine—kidney cancer	0.000432	0.00133	CcSEcCtD
Prasugrel—Nausea—Pazopanib—kidney cancer	0.000428	0.00132	CcSEcCtD
Prasugrel—Ecchymosis—Doxorubicin—kidney cancer	0.000428	0.00132	CcSEcCtD
Prasugrel—Neoplasm—Doxorubicin—kidney cancer	0.000428	0.00132	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000426	0.00131	CcSEcCtD
Prasugrel—Fatigue—Sorafenib—kidney cancer	0.000426	0.00131	CcSEcCtD
Prasugrel—Hypertension—Vincristine—kidney cancer	0.000425	0.00131	CcSEcCtD
Prasugrel—Dyspnoea—Sunitinib—kidney cancer	0.000424	0.0013	CcSEcCtD
Prasugrel—Hypersensitivity—Vinblastine—kidney cancer	0.000421	0.0013	CcSEcCtD
Prasugrel—Eye disorder—Paclitaxel—kidney cancer	0.00042	0.00129	CcSEcCtD
Prasugrel—Hypersensitivity—Everolimus—kidney cancer	0.000419	0.00129	CcSEcCtD
Prasugrel—Leukopenia—Gemcitabine—kidney cancer	0.000418	0.00129	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00041	0.00126	CcSEcCtD
Prasugrel—Asthenia—Vinblastine—kidney cancer	0.00041	0.00126	CcSEcCtD
Prasugrel—Fatigue—Sunitinib—kidney cancer	0.00041	0.00126	CcSEcCtD
Prasugrel—Asthenia—Everolimus—kidney cancer	0.000408	0.00126	CcSEcCtD
Prasugrel—Cough—Gemcitabine—kidney cancer	0.000408	0.00126	CcSEcCtD
Prasugrel—Angiopathy—Paclitaxel—kidney cancer	0.000408	0.00126	CcSEcCtD
Prasugrel—Immune system disorder—Paclitaxel—kidney cancer	0.000406	0.00125	CcSEcCtD
Prasugrel—Mediastinal disorder—Paclitaxel—kidney cancer	0.000405	0.00125	CcSEcCtD
Prasugrel—Hypertension—Gemcitabine—kidney cancer	0.000403	0.00124	CcSEcCtD
Prasugrel—Anaphylactic shock—Vincristine—kidney cancer	0.000402	0.00124	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000395	0.00122	CcSEcCtD
Prasugrel—Asthenia—Erlotinib—kidney cancer	0.000394	0.00121	CcSEcCtD
Prasugrel—Thrombocytopenia—Vincristine—kidney cancer	0.000394	0.00121	CcSEcCtD
Prasugrel—Haematuria—Capecitabine—kidney cancer	0.000392	0.00121	CcSEcCtD
Prasugrel—Diarrhoea—Vinblastine—kidney cancer	0.000391	0.0012	CcSEcCtD
Prasugrel—Body temperature increased—Sorafenib—kidney cancer	0.00039	0.0012	CcSEcCtD
Prasugrel—Diarrhoea—Everolimus—kidney cancer	0.000389	0.0012	CcSEcCtD
Prasugrel—Fatigue—Dactinomycin—kidney cancer	0.000388	0.00119	CcSEcCtD
Prasugrel—Epistaxis—Capecitabine—kidney cancer	0.000387	0.00119	CcSEcCtD
Prasugrel—Anaphylactic shock—Gemcitabine—kidney cancer	0.000381	0.00117	CcSEcCtD
Prasugrel—Back pain—Paclitaxel—kidney cancer	0.000378	0.00116	CcSEcCtD
Prasugrel—Dizziness—Vinblastine—kidney cancer	0.000378	0.00116	CcSEcCtD
Prasugrel—Dizziness—Everolimus—kidney cancer	0.000376	0.00116	CcSEcCtD
Prasugrel—Body temperature increased—Sunitinib—kidney cancer	0.000376	0.00116	CcSEcCtD
Prasugrel—Diarrhoea—Erlotinib—kidney cancer	0.000376	0.00116	CcSEcCtD
Prasugrel—Hypotension—Vincristine—kidney cancer	0.000376	0.00116	CcSEcCtD
Prasugrel—Bradycardia—Capecitabine—kidney cancer	0.000375	0.00116	CcSEcCtD
Prasugrel—Thrombocytopenia—Gemcitabine—kidney cancer	0.000373	0.00115	CcSEcCtD
Prasugrel—Haemoglobin—Capecitabine—kidney cancer	0.000371	0.00114	CcSEcCtD
Prasugrel—Skin disorder—Gemcitabine—kidney cancer	0.00037	0.00114	CcSEcCtD
Prasugrel—Haemorrhage—Capecitabine—kidney cancer	0.000369	0.00114	CcSEcCtD
Prasugrel—Urinary tract disorder—Capecitabine—kidney cancer	0.000364	0.00112	CcSEcCtD
Prasugrel—Hypersensitivity—Sorafenib—kidney cancer	0.000364	0.00112	CcSEcCtD
Prasugrel—Oedema peripheral—Capecitabine—kidney cancer	0.000363	0.00112	CcSEcCtD
Prasugrel—Dizziness—Erlotinib—kidney cancer	0.000363	0.00112	CcSEcCtD
Prasugrel—Anaemia—Paclitaxel—kidney cancer	0.000362	0.00111	CcSEcCtD
Prasugrel—Urethral disorder—Capecitabine—kidney cancer	0.000362	0.00111	CcSEcCtD
Prasugrel—Rash—Everolimus—kidney cancer	0.000359	0.0011	CcSEcCtD
Prasugrel—Dermatitis—Everolimus—kidney cancer	0.000358	0.0011	CcSEcCtD
Prasugrel—Headache—Vinblastine—kidney cancer	0.000358	0.0011	CcSEcCtD
Prasugrel—Angioedema—Paclitaxel—kidney cancer	0.000357	0.0011	CcSEcCtD
Prasugrel—Headache—Everolimus—kidney cancer	0.000356	0.0011	CcSEcCtD
Prasugrel—Hypotension—Gemcitabine—kidney cancer	0.000356	0.0011	CcSEcCtD
Prasugrel—Body temperature increased—Dactinomycin—kidney cancer	0.000356	0.00109	CcSEcCtD
Prasugrel—Asthenia—Sorafenib—kidney cancer	0.000354	0.00109	CcSEcCtD
Prasugrel—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000351	0.00108	CcSEcCtD
Prasugrel—Leukopenia—Paclitaxel—kidney cancer	0.00035	0.00108	CcSEcCtD
Prasugrel—Hypersensitivity—Sunitinib—kidney cancer	0.00035	0.00108	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Vincristine—kidney cancer	0.000347	0.00107	CcSEcCtD
Prasugrel—Fatigue—Vincristine—kidney cancer	0.000347	0.00107	CcSEcCtD
Prasugrel—Rash—Erlotinib—kidney cancer	0.000346	0.00107	CcSEcCtD
Prasugrel—Dermatitis—Erlotinib—kidney cancer	0.000346	0.00106	CcSEcCtD
Prasugrel—Eye disorder—Capecitabine—kidney cancer	0.000345	0.00106	CcSEcCtD
Prasugrel—Headache—Erlotinib—kidney cancer	0.000344	0.00106	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000344	0.00106	CcSEcCtD
Prasugrel—Pain in extremity—Doxorubicin—kidney cancer	0.000344	0.00106	CcSEcCtD
Prasugrel—Cough—Paclitaxel—kidney cancer	0.000341	0.00105	CcSEcCtD
Prasugrel—Asthenia—Sunitinib—kidney cancer	0.000341	0.00105	CcSEcCtD
Prasugrel—Dyspnoea—Gemcitabine—kidney cancer	0.00034	0.00105	CcSEcCtD
Prasugrel—Nausea—Vinblastine—kidney cancer	0.000339	0.00104	CcSEcCtD
Prasugrel—Nausea—Everolimus—kidney cancer	0.000338	0.00104	CcSEcCtD
Prasugrel—Diarrhoea—Sorafenib—kidney cancer	0.000338	0.00104	CcSEcCtD
Prasugrel—Hypertension—Paclitaxel—kidney cancer	0.000338	0.00104	CcSEcCtD
Prasugrel—Angiopathy—Capecitabine—kidney cancer	0.000335	0.00103	CcSEcCtD
Prasugrel—Immune system disorder—Capecitabine—kidney cancer	0.000333	0.00103	CcSEcCtD
Prasugrel—Mediastinal disorder—Capecitabine—kidney cancer	0.000332	0.00102	CcSEcCtD
Prasugrel—Hypersensitivity—Dactinomycin—kidney cancer	0.000331	0.00102	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000331	0.00102	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000329	0.00101	CcSEcCtD
Prasugrel—Fatigue—Gemcitabine—kidney cancer	0.000329	0.00101	CcSEcCtD
Prasugrel—Dizziness—Sorafenib—kidney cancer	0.000327	0.00101	CcSEcCtD
Prasugrel—Nausea—Erlotinib—kidney cancer	0.000326	0.001	CcSEcCtD
Prasugrel—Diarrhoea—Sunitinib—kidney cancer	0.000325	0.001	CcSEcCtD
Prasugrel—Asthenia—Dactinomycin—kidney cancer	0.000323	0.000994	CcSEcCtD
Prasugrel—Anaphylactic shock—Paclitaxel—kidney cancer	0.000319	0.000983	CcSEcCtD
Prasugrel—Body temperature increased—Vincristine—kidney cancer	0.000318	0.000978	CcSEcCtD
Prasugrel—Dizziness—Sunitinib—kidney cancer	0.000314	0.000967	CcSEcCtD
Prasugrel—Thrombocytopenia—Paclitaxel—kidney cancer	0.000313	0.000962	CcSEcCtD
Prasugrel—Rash—Sorafenib—kidney cancer	0.000311	0.000959	CcSEcCtD
Prasugrel—Dermatitis—Sorafenib—kidney cancer	0.000311	0.000958	CcSEcCtD
Prasugrel—Back pain—Capecitabine—kidney cancer	0.000311	0.000956	CcSEcCtD
Prasugrel—Skin disorder—Paclitaxel—kidney cancer	0.00031	0.000955	CcSEcCtD
Prasugrel—Headache—Sorafenib—kidney cancer	0.000309	0.000953	CcSEcCtD
Prasugrel—Diarrhoea—Dactinomycin—kidney cancer	0.000308	0.000948	CcSEcCtD
Prasugrel—Body temperature increased—Gemcitabine—kidney cancer	0.000301	0.000928	CcSEcCtD
Prasugrel—Rash—Sunitinib—kidney cancer	0.0003	0.000922	CcSEcCtD
Prasugrel—Dermatitis—Sunitinib—kidney cancer	0.000299	0.000922	CcSEcCtD
Prasugrel—Hypotension—Paclitaxel—kidney cancer	0.000298	0.000918	CcSEcCtD
Prasugrel—Headache—Sunitinib—kidney cancer	0.000298	0.000917	CcSEcCtD
Prasugrel—Anaemia—Capecitabine—kidney cancer	0.000297	0.000913	CcSEcCtD
Prasugrel—Hypersensitivity—Vincristine—kidney cancer	0.000296	0.000912	CcSEcCtD
Prasugrel—Nausea—Sorafenib—kidney cancer	0.000293	0.000903	CcSEcCtD
Prasugrel—Asthenia—Vincristine—kidney cancer	0.000288	0.000888	CcSEcCtD
Prasugrel—Leukopenia—Capecitabine—kidney cancer	0.000287	0.000885	CcSEcCtD
Prasugrel—Dyspnoea—Paclitaxel—kidney cancer	0.000285	0.000876	CcSEcCtD
Prasugrel—Rash—Dactinomycin—kidney cancer	0.000284	0.000873	CcSEcCtD
Prasugrel—Nausea—Sunitinib—kidney cancer	0.000282	0.000869	CcSEcCtD
Prasugrel—Cough—Capecitabine—kidney cancer	0.00028	0.000862	CcSEcCtD
Prasugrel—Hypertension—Capecitabine—kidney cancer	0.000277	0.000853	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000276	0.000849	CcSEcCtD
Prasugrel—Fatigue—Paclitaxel—kidney cancer	0.000275	0.000847	CcSEcCtD
Prasugrel—Diarrhoea—Vincristine—kidney cancer	0.000275	0.000847	CcSEcCtD
Prasugrel—Asthenia—Gemcitabine—kidney cancer	0.000274	0.000842	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000271	0.000836	CcSEcCtD
Prasugrel—Nausea—Dactinomycin—kidney cancer	0.000267	0.000823	CcSEcCtD
Prasugrel—Dizziness—Vincristine—kidney cancer	0.000266	0.000818	CcSEcCtD
Prasugrel—Diarrhoea—Gemcitabine—kidney cancer	0.000261	0.000803	CcSEcCtD
Prasugrel—Thrombocytopenia—Capecitabine—kidney cancer	0.000257	0.00079	CcSEcCtD
Prasugrel—Skin disorder—Capecitabine—kidney cancer	0.000254	0.000783	CcSEcCtD
Prasugrel—Rash—Vincristine—kidney cancer	0.000253	0.00078	CcSEcCtD
Prasugrel—Dermatitis—Vincristine—kidney cancer	0.000253	0.00078	CcSEcCtD
Prasugrel—Haematuria—Doxorubicin—kidney cancer	0.000252	0.000777	CcSEcCtD
Prasugrel—Body temperature increased—Paclitaxel—kidney cancer	0.000252	0.000777	CcSEcCtD
Prasugrel—Headache—Vincristine—kidney cancer	0.000252	0.000775	CcSEcCtD
Prasugrel—Epistaxis—Doxorubicin—kidney cancer	0.00025	0.000769	CcSEcCtD
Prasugrel—Hypotension—Capecitabine—kidney cancer	0.000245	0.000754	CcSEcCtD
Prasugrel—Bradycardia—Doxorubicin—kidney cancer	0.000242	0.000745	CcSEcCtD
Prasugrel—Rash—Gemcitabine—kidney cancer	0.00024	0.00074	CcSEcCtD
Prasugrel—Dermatitis—Gemcitabine—kidney cancer	0.00024	0.00074	CcSEcCtD
Prasugrel—Haemoglobin—Doxorubicin—kidney cancer	0.000239	0.000736	CcSEcCtD
Prasugrel—Headache—Gemcitabine—kidney cancer	0.000239	0.000735	CcSEcCtD
Prasugrel—Nausea—Vincristine—kidney cancer	0.000239	0.000735	CcSEcCtD
Prasugrel—Haemorrhage—Doxorubicin—kidney cancer	0.000238	0.000732	CcSEcCtD
Prasugrel—Hypersensitivity—Paclitaxel—kidney cancer	0.000235	0.000724	CcSEcCtD
Prasugrel—Urinary tract disorder—Doxorubicin—kidney cancer	0.000235	0.000723	CcSEcCtD
Prasugrel—Oedema peripheral—Doxorubicin—kidney cancer	0.000234	0.000721	CcSEcCtD
Prasugrel—Dyspnoea—Capecitabine—kidney cancer	0.000234	0.000719	CcSEcCtD
Prasugrel—Urethral disorder—Doxorubicin—kidney cancer	0.000233	0.000717	CcSEcCtD
Prasugrel—Asthenia—Paclitaxel—kidney cancer	0.000229	0.000705	CcSEcCtD
Prasugrel—Nausea—Gemcitabine—kidney cancer	0.000227	0.000697	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000226	0.000696	CcSEcCtD
Prasugrel—Fatigue—Capecitabine—kidney cancer	0.000226	0.000695	CcSEcCtD
Prasugrel—Eye disorder—Doxorubicin—kidney cancer	0.000222	0.000684	CcSEcCtD
Prasugrel—Diarrhoea—Paclitaxel—kidney cancer	0.000218	0.000672	CcSEcCtD
Prasugrel—Angiopathy—Doxorubicin—kidney cancer	0.000216	0.000664	CcSEcCtD
Prasugrel—Immune system disorder—Doxorubicin—kidney cancer	0.000215	0.000661	CcSEcCtD
Prasugrel—Mediastinal disorder—Doxorubicin—kidney cancer	0.000214	0.00066	CcSEcCtD
Prasugrel—Dizziness—Paclitaxel—kidney cancer	0.000211	0.00065	CcSEcCtD
Prasugrel—Body temperature increased—Capecitabine—kidney cancer	0.000207	0.000638	CcSEcCtD
Prasugrel—Rash—Paclitaxel—kidney cancer	0.000201	0.00062	CcSEcCtD
Prasugrel—Dermatitis—Paclitaxel—kidney cancer	0.000201	0.000619	CcSEcCtD
Prasugrel—Back pain—Doxorubicin—kidney cancer	0.0002	0.000616	CcSEcCtD
Prasugrel—Headache—Paclitaxel—kidney cancer	0.0002	0.000616	CcSEcCtD
Prasugrel—Hypersensitivity—Capecitabine—kidney cancer	0.000193	0.000594	CcSEcCtD
Prasugrel—Anaemia—Doxorubicin—kidney cancer	0.000191	0.000589	CcSEcCtD
Prasugrel—Nausea—Paclitaxel—kidney cancer	0.00019	0.000584	CcSEcCtD
Prasugrel—Asthenia—Capecitabine—kidney cancer	0.000188	0.000579	CcSEcCtD
Prasugrel—Leukopenia—Doxorubicin—kidney cancer	0.000185	0.00057	CcSEcCtD
Prasugrel—Cough—Doxorubicin—kidney cancer	0.000181	0.000556	CcSEcCtD
Prasugrel—Diarrhoea—Capecitabine—kidney cancer	0.000179	0.000552	CcSEcCtD
Prasugrel—Hypertension—Doxorubicin—kidney cancer	0.000179	0.00055	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000175	0.000539	CcSEcCtD
Prasugrel—Dizziness—Capecitabine—kidney cancer	0.000173	0.000533	CcSEcCtD
Prasugrel—Anaphylactic shock—Doxorubicin—kidney cancer	0.000169	0.00052	CcSEcCtD
Prasugrel—Thrombocytopenia—Doxorubicin—kidney cancer	0.000165	0.000509	CcSEcCtD
Prasugrel—Rash—Capecitabine—kidney cancer	0.000165	0.000509	CcSEcCtD
Prasugrel—Dermatitis—Capecitabine—kidney cancer	0.000165	0.000508	CcSEcCtD
Prasugrel—Headache—Capecitabine—kidney cancer	0.000164	0.000505	CcSEcCtD
Prasugrel—Skin disorder—Doxorubicin—kidney cancer	0.000164	0.000505	CcSEcCtD
Prasugrel—Hypotension—Doxorubicin—kidney cancer	0.000158	0.000486	CcSEcCtD
Prasugrel—Nausea—Capecitabine—kidney cancer	0.000156	0.000479	CcSEcCtD
Prasugrel—Dyspnoea—Doxorubicin—kidney cancer	0.000151	0.000464	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000146	0.000449	CcSEcCtD
Prasugrel—Fatigue—Doxorubicin—kidney cancer	0.000146	0.000448	CcSEcCtD
Prasugrel—Body temperature increased—Doxorubicin—kidney cancer	0.000134	0.000411	CcSEcCtD
Prasugrel—Hypersensitivity—Doxorubicin—kidney cancer	0.000124	0.000383	CcSEcCtD
Prasugrel—Asthenia—Doxorubicin—kidney cancer	0.000121	0.000373	CcSEcCtD
Prasugrel—Diarrhoea—Doxorubicin—kidney cancer	0.000116	0.000356	CcSEcCtD
Prasugrel—Dizziness—Doxorubicin—kidney cancer	0.000112	0.000344	CcSEcCtD
Prasugrel—Rash—Doxorubicin—kidney cancer	0.000106	0.000328	CcSEcCtD
Prasugrel—Dermatitis—Doxorubicin—kidney cancer	0.000106	0.000328	CcSEcCtD
Prasugrel—Headache—Doxorubicin—kidney cancer	0.000106	0.000326	CcSEcCtD
Prasugrel—Nausea—Doxorubicin—kidney cancer	0.0001	0.000309	CcSEcCtD
Prasugrel—P2RY12—Signaling Pathways—CDKN2B—kidney cancer	4.34e-05	0.00062	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.3e-05	0.000615	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GPC3—kidney cancer	4.28e-05	0.000613	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CCBL1—kidney cancer	4.27e-05	0.000611	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IGF1R—kidney cancer	4.21e-05	0.000602	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—PIK3CA—kidney cancer	4.21e-05	0.000602	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—GSTP1—kidney cancer	4.19e-05	0.0006	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CA2—kidney cancer	4.17e-05	0.000596	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.15e-05	0.000594	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PDHB—kidney cancer	4.14e-05	0.000592	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.14e-05	0.000591	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—POMC—kidney cancer	4.13e-05	0.000591	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GLIPR1—kidney cancer	4.13e-05	0.00059	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPAT—kidney cancer	4.13e-05	0.00059	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.07e-05	0.000583	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TP53—kidney cancer	4.07e-05	0.000582	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALAD—kidney cancer	4.06e-05	0.000581	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—RAF1—kidney cancer	4.06e-05	0.00058	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.03e-05	0.000577	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—IL2—kidney cancer	4.01e-05	0.000573	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ST3GAL2—kidney cancer	3.96e-05	0.000567	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CCBL1—kidney cancer	3.89e-05	0.000557	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALDH1A1—kidney cancer	3.87e-05	0.000554	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.86e-05	0.000552	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.85e-05	0.000551	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APRT—kidney cancer	3.84e-05	0.000549	CbGpPWpGaD
Prasugrel—ALB—Metabolism—FH—kidney cancer	3.84e-05	0.000549	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IFNA1—kidney cancer	3.8e-05	0.000544	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.8e-05	0.000543	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.75e-05	0.000536	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PGK1—kidney cancer	3.71e-05	0.000531	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SLC5A3—kidney cancer	3.71e-05	0.000531	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPAT—kidney cancer	3.7e-05	0.00053	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GLIPR1—kidney cancer	3.7e-05	0.00053	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.66e-05	0.000523	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.65e-05	0.000522	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—LDHB—kidney cancer	3.64e-05	0.000521	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—IL2—kidney cancer	3.64e-05	0.00052	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.62e-05	0.000518	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GPC3—kidney cancer	3.61e-05	0.000516	CbGpPWpGaD
Prasugrel—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.6e-05	0.000515	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IFNA2—kidney cancer	3.54e-05	0.000506	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.52e-05	0.000504	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.52e-05	0.000504	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CA2—kidney cancer	3.51e-05	0.000502	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HIF1A—kidney cancer	3.47e-05	0.000496	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TSC2—kidney cancer	3.46e-05	0.000494	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—FH—kidney cancer	3.44e-05	0.000492	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APRT—kidney cancer	3.44e-05	0.000492	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ALAD—kidney cancer	3.42e-05	0.000489	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	3.4e-05	0.000487	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.4e-05	0.000486	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GLIPR1—kidney cancer	3.38e-05	0.000483	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPAT—kidney cancer	3.38e-05	0.000483	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.37e-05	0.000481	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ST3GAL2—kidney cancer	3.34e-05	0.000477	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.33e-05	0.000477	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KDR—kidney cancer	3.31e-05	0.000474	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.3e-05	0.000472	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ALDH1A1—kidney cancer	3.26e-05	0.000466	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GPC3—kidney cancer	3.24e-05	0.000463	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ACY1—kidney cancer	3.21e-05	0.000459	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IGF2—kidney cancer	3.19e-05	0.000456	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CA9—kidney cancer	3.16e-05	0.000452	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CA2—kidney cancer	3.15e-05	0.00045	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APRT—kidney cancer	3.14e-05	0.000449	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—FH—kidney cancer	3.14e-05	0.000449	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PGK1—kidney cancer	3.13e-05	0.000447	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC5A3—kidney cancer	3.13e-05	0.000447	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALAD—kidney cancer	3.07e-05	0.000439	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.07e-05	0.000439	CbGpPWpGaD
Prasugrel—ALB—Metabolism—LDHB—kidney cancer	3.07e-05	0.000438	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KIT—kidney cancer	3.05e-05	0.000437	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—APC—kidney cancer	3.05e-05	0.000437	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	3.05e-05	0.000436	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ST3GAL2—kidney cancer	3e-05	0.000428	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GPC3—kidney cancer	2.95e-05	0.000422	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.93e-05	0.000419	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—MAPK3—kidney cancer	2.92e-05	0.000418	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—POMC—kidney cancer	2.91e-05	0.000416	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CA2—kidney cancer	2.87e-05	0.000411	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—BRAF—kidney cancer	2.87e-05	0.00041	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PGK1—kidney cancer	2.81e-05	0.000401	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.81e-05	0.000401	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALAD—kidney cancer	2.8e-05	0.0004	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—MAPK1—kidney cancer	2.78e-05	0.000398	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—LDHB—kidney cancer	2.75e-05	0.000394	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PDHB—kidney cancer	2.73e-05	0.000391	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.73e-05	0.000391	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—POMC—kidney cancer	2.72e-05	0.000389	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CRABP1—kidney cancer	2.69e-05	0.000384	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.68e-05	0.000384	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.67e-05	0.000382	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PIK3CA—kidney cancer	2.66e-05	0.00038	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CA9—kidney cancer	2.66e-05	0.00038	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—KRAS—kidney cancer	2.63e-05	0.000376	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.6e-05	0.000372	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.59e-05	0.000371	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CCBL1—kidney cancer	2.57e-05	0.000367	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.56e-05	0.000366	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PGK1—kidney cancer	2.56e-05	0.000366	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—LDHB—kidney cancer	2.51e-05	0.000359	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ITPR2—kidney cancer	2.5e-05	0.000357	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.45e-05	0.000351	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PIK3CA—kidney cancer	2.41e-05	0.000345	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—RAF1—kidney cancer	2.4e-05	0.000343	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CA9—kidney cancer	2.39e-05	0.000341	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—RELA—kidney cancer	2.39e-05	0.000341	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ERBB2—kidney cancer	2.37e-05	0.000339	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MTOR—kidney cancer	2.34e-05	0.000335	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.33e-05	0.000334	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.33e-05	0.000334	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTT1—kidney cancer	2.28e-05	0.000326	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ACHE—kidney cancer	2.28e-05	0.000326	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CRABP1—kidney cancer	2.26e-05	0.000323	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPAT—kidney cancer	2.23e-05	0.000318	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.23e-05	0.000318	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CDKN1B—kidney cancer	2.2e-05	0.000314	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CA9—kidney cancer	2.18e-05	0.000311	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SCARB1—kidney cancer	2.16e-05	0.000308	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL2—kidney cancer	2.15e-05	0.000307	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS1—kidney cancer	2.13e-05	0.000305	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.13e-05	0.000304	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ITPR2—kidney cancer	2.1e-05	0.000301	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCND1—kidney cancer	2.09e-05	0.0003	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PSMD7—kidney cancer	2.09e-05	0.000299	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—JUN—kidney cancer	2.09e-05	0.000299	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CTNNB1—kidney cancer	2.07e-05	0.000297	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—FH—kidney cancer	2.07e-05	0.000296	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APRT—kidney cancer	2.07e-05	0.000296	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CRABP1—kidney cancer	2.03e-05	0.00029	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2.03e-05	0.00029	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTEN—kidney cancer	2.02e-05	0.000289	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—BCHE—kidney cancer	1.98e-05	0.000284	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.96e-05	0.00028	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GPC3—kidney cancer	1.95e-05	0.000278	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.94e-05	0.000277	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ACHE—kidney cancer	1.92e-05	0.000274	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTT1—kidney cancer	1.92e-05	0.000274	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CA2—kidney cancer	1.89e-05	0.000271	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.89e-05	0.000271	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ITPR2—kidney cancer	1.89e-05	0.00027	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CRABP1—kidney cancer	1.85e-05	0.000265	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALAD—kidney cancer	1.85e-05	0.000264	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—VEGFA—kidney cancer	1.83e-05	0.000261	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SCARB1—kidney cancer	1.81e-05	0.000259	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.8e-05	0.000258	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS1—kidney cancer	1.8e-05	0.000257	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PSMD7—kidney cancer	1.76e-05	0.000252	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.76e-05	0.000252	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—RAF1—kidney cancer	1.75e-05	0.000251	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.74e-05	0.000249	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAPK3—kidney cancer	1.73e-05	0.000247	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTT1—kidney cancer	1.72e-05	0.000246	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ACHE—kidney cancer	1.72e-05	0.000246	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ITPR2—kidney cancer	1.72e-05	0.000246	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.69e-05	0.000241	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PGK1—kidney cancer	1.69e-05	0.000241	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—kidney cancer	1.68e-05	0.00024	CbGpPWpGaD
Prasugrel—ALB—Metabolism—BCHE—kidney cancer	1.67e-05	0.000239	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LDHB—kidney cancer	1.66e-05	0.000237	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC5A5—kidney cancer	1.65e-05	0.000236	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAPK1—kidney cancer	1.64e-05	0.000235	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SCARB1—kidney cancer	1.63e-05	0.000233	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS1—kidney cancer	1.61e-05	0.000231	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC2A1—kidney cancer	1.59e-05	0.000228	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.59e-05	0.000227	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PSMD7—kidney cancer	1.58e-05	0.000226	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTP1—kidney cancer	1.58e-05	0.000226	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—IL2—kidney cancer	1.57e-05	0.000225	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ACHE—kidney cancer	1.57e-05	0.000224	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTT1—kidney cancer	1.57e-05	0.000224	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—KRAS—kidney cancer	1.55e-05	0.000222	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.55e-05	0.000221	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.52e-05	0.000217	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—BCHE—kidney cancer	1.5e-05	0.000214	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ABCB1—kidney cancer	1.49e-05	0.000214	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SCARB1—kidney cancer	1.48e-05	0.000212	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.48e-05	0.000212	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS1—kidney cancer	1.47e-05	0.00021	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTM1—kidney cancer	1.45e-05	0.000207	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PSMD7—kidney cancer	1.44e-05	0.000206	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CA9—kidney cancer	1.44e-05	0.000205	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.43e-05	0.000204	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PIK3CA—kidney cancer	1.43e-05	0.000204	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.39e-05	0.000198	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—kidney cancer	1.38e-05	0.000197	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.37e-05	0.000197	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—BCHE—kidney cancer	1.37e-05	0.000195	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.35e-05	0.000193	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.35e-05	0.000193	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—kidney cancer	1.34e-05	0.000191	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTP1—kidney cancer	1.33e-05	0.00019	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.3e-05	0.000186	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.26e-05	0.000181	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MAPK3—kidney cancer	1.26e-05	0.000181	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ABCB1—kidney cancer	1.26e-05	0.00018	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTM1—kidney cancer	1.22e-05	0.000175	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CRABP1—kidney cancer	1.22e-05	0.000175	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.21e-05	0.000173	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—MAPK1—kidney cancer	1.2e-05	0.000172	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTP1—kidney cancer	1.19e-05	0.000171	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP1A1—kidney cancer	1.16e-05	0.000165	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—KRAS—kidney cancer	1.14e-05	0.000163	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ITPR2—kidney cancer	1.13e-05	0.000162	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ABCB1—kidney cancer	1.13e-05	0.000161	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.1e-05	0.000158	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTM1—kidney cancer	1.1e-05	0.000157	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTP1—kidney cancer	1.09e-05	0.000155	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3CA—kidney cancer	1.04e-05	0.000149	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.04e-05	0.000149	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTT1—kidney cancer	1.03e-05	0.000148	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ACHE—kidney cancer	1.03e-05	0.000148	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ABCB1—kidney cancer	1.03e-05	0.000147	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—POMC—kidney cancer	1.02e-05	0.000147	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—kidney cancer	1.01e-05	0.000144	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTM1—kidney cancer	9.99e-06	0.000143	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SCARB1—kidney cancer	9.79e-06	0.00014	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS1—kidney cancer	9.69e-06	0.000139	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.51e-06	0.000136	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PSMD7—kidney cancer	9.51e-06	0.000136	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP1A1—kidney cancer	9.47e-06	0.000135	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—BCHE—kidney cancer	9.01e-06	0.000129	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.9e-06	0.000127	CbGpPWpGaD
Prasugrel—ALB—Metabolism—POMC—kidney cancer	8.63e-06	0.000123	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.6e-06	0.000123	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.53e-06	0.000122	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS2—kidney cancer	8.18e-06	0.000117	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.78e-06	0.000111	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—POMC—kidney cancer	7.75e-06	0.000111	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTP1—kidney cancer	7.17e-06	0.000103	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTEN—kidney cancer	7.13e-06	0.000102	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—POMC—kidney cancer	7.06e-06	0.000101	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS2—kidney cancer	6.88e-06	9.84e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCB1—kidney cancer	6.79e-06	9.71e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTM1—kidney cancer	6.59e-06	9.42e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.25e-06	8.93e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS2—kidney cancer	6.18e-06	8.83e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTEN—kidney cancer	6e-06	8.58e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS2—kidney cancer	5.63e-06	8.06e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTEN—kidney cancer	5.39e-06	7.7e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3CA—kidney cancer	5.03e-06	7.19e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTEN—kidney cancer	4.91e-06	7.03e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—POMC—kidney cancer	4.66e-06	6.66e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3CA—kidney cancer	4.23e-06	6.05e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.8e-06	5.44e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS2—kidney cancer	3.71e-06	5.31e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.47e-06	4.96e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTEN—kidney cancer	3.24e-06	4.63e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.29e-06	3.27e-05	CbGpPWpGaD
